{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:54:10Z","timestamp":1786679650882,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T00:00:00Z","timestamp":1544227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00787-018-1244-7","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T12:16:04Z","timestamp":1544271364000},"page":"253-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Ramona","family":"Meister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Antel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triinu","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Bingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Nestoriuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hebebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,8]]},"reference":[{"issue":"11","key":"1244_CR1","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA (2013) Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 10(11):e1001547. \nhttps:\/\/doi.org\/10.1371\/journal.pmed.1001547","journal-title":"PLoS Med"},{"key":"1244_CR2","unstructured":"WHO (2012) Depression. \nhttp:\/\/www.who.int\/mental_health\/management\/depression\/\n\n. Accessed 21 Aug 2012"},{"issue":"23","key":"1244_CR3","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1001\/jama.289.23.3135","volume":"289","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D (2003) Cost of lost productive work time among US workers with depression. JAMA J Am Med Assoc 289(23):3135\u20133144. \nhttps:\/\/doi.org\/10.1001\/jama.289.23.3135","journal-title":"JAMA J Am Med Assoc"},{"issue":"2","key":"1244_CR4","first-page":"87","volume":"9","author":"P Sobocki","year":"2006","unstructured":"Sobocki P, Jonsson B, Angst J, Rehnberg C (2006) Cost of depression in Europe. J ment Health Policy Econ 9(2):87\u201398","journal-title":"J ment Health Policy Econ"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-publhealth-031811-124544","volume":"33","author":"CF Reynolds 3rd","year":"2012","unstructured":"Reynolds CF 3rd, Cuijpers P, Patel V, Cohen A, Dias A, Chowdhary N, Okereke OI, Dew MA, Anderson SJ, Mazumdar S, Lotrich F, Albert SM (2012) Early intervention to reduce the global health and economic burden of major depression in older adults. Annu Rev Public Health 33:123\u2013135. \nhttps:\/\/doi.org\/10.1146\/annurev-publhealth-031811-124544","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"1244_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/da.20115","volume":"22","author":"CA Essau","year":"2005","unstructured":"Essau CA (2005) Frequency and patterns of mental health services utilization among adolescents with anxiety and depressive disorders. Depress Anxiety 22(3):130\u2013137. \nhttps:\/\/doi.org\/10.1002\/da.20115","journal-title":"Depress Anxiety"},{"key":"1244_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2013.06.001","author":"V Reissner","year":"2013","unstructured":"Reissner V, Muhe B, Wellenbrock S, Kuhnigk O, Kis B, Dietrich H, Hebebrand J (2013) DSM-IV-TR axes-I and II mental disorders in a representative and referred sample of unemployed youths\u2014results from a psychiatric liaison service in a job centre. Eur Psychiatry J Assoc Eur Psychiatr. \nhttps:\/\/doi.org\/10.1016\/j.eurpsy.2013.06.001","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"issue":"9","key":"1244_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","volume":"21","author":"HU Wittchen","year":"2011","unstructured":"Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 21(9):655\u2013679. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2011.07.018","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"12","key":"1244_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1469-7610.2006.01682.x","volume":"47","author":"E Jane Costello","year":"2006","unstructured":"Jane Costello E, Erkanli A, Angold A (2006) Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 47(12):1263\u20131271. \nhttps:\/\/doi.org\/10.1111\/j.1469-7610.2006.01682.x","journal-title":"J Child Psychol Psychiatry"},{"issue":"9820","key":"1244_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0140-6736(11)60871-4","volume":"379","author":"A Thapar","year":"2012","unstructured":"Thapar A, Collishaw S, Pine DS, Thapar AK (2012) Depress Adolesc. Lancet 379(9820):1056\u20131067. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(11)60871-4","journal-title":"Lancet"},{"issue":"1","key":"1244_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/YCO.0b013e328334bd2c","volume":"23","author":"J Hebebrand","year":"2010","unstructured":"Hebebrand J (2010) Commentary on \u2018Forum: use of antidepressants in children and adolescents\u2019. Curr opin Psychiatry 23(1):62\u201363. \nhttps:\/\/doi.org\/10.1097\/YCO.0b013e328334bd2c","journal-title":"Curr opin Psychiatry"},{"issue":"11","key":"1244_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1055\/s-0033-1355843","volume":"81","author":"M Lambert","year":"2013","unstructured":"Lambert M, Bock T, Naber D, Lowe B, Schulte-Markwort M, Schafer I, Gumz A, Degkwitz P, Schulte B, Konig HH, Konnopka A, Bauer M, Bechdolf A, Correll C, Juckel G, Klosterkotter J, Leopold K, Pfennig A, Karow A (2013) Mental health of children, adolescents and young adults\u2014part 1: prevalence, illness persistence, adversities, service use, treatment delay and consequences. Fortschr Neurol Psychiatr 81(11):614\u2013627. \nhttps:\/\/doi.org\/10.1055\/s-0033-1355843","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"11","key":"1244_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1055\/s-0033-1355840","volume":"81","author":"A Karow","year":"2013","unstructured":"Karow A, Bock T, Naber D, Lowe B, Schulte-Markwort M, Schafer I, Gumz A, Degkwitz P, Schulte B, Konig HH, Konnopka A, Bauer M, Bechdolf A, Correll C, Juckel G, Klosterkotter J, Leopold K, Pfennig A, Lambert M (2013) Mental health of children, adolescents and young adults\u2014part 2: burden of illness, deficits of the german health care system and efficacy and effectiveness of early intervention services. Fortschr Neurol Psychiatr 81(11):628\u2013638. \nhttps:\/\/doi.org\/10.1055\/s-0033-1355840","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"3","key":"1244_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jad.2010.10.046","volume":"130","author":"U Jonsson","year":"2011","unstructured":"Jonsson U, Bohman H, von Knorring L, Olsson G, Paaren A, von Knorring AL (2011) Mental health outcome of long-term and episodic adolescent depression: 15-year follow-up of a community sample. J Affect Disord 130(3):395\u2013404. \nhttps:\/\/doi.org\/10.1016\/j.jad.2010.10.046","journal-title":"J Affect Disord"},{"issue":"2","key":"1244_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1469-7610.2010.02309.x","volume":"52","author":"M Holtmann","year":"2011","unstructured":"Holtmann M, Buchmann AF, Esser G, Schmidt MH, Banaschewski T, Laucht M (2011) The child behavior checklist-dysregulation profile predicts substance use, suicidality, and functional impairment: a longitudinal analysis. J Child Psychol Psychiatry 52(2):139\u2013147. \nhttps:\/\/doi.org\/10.1111\/j.1469-7610.2010.02309.x","journal-title":"J Child Psychol Psychiatry"},{"issue":"8","key":"1244_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11920-013-0381-4","volume":"15","author":"AH Cheung","year":"2013","unstructured":"Cheung AH, Kozloff N, Sacks D (2013) Pediatric depression: an evidence-based update on treatment interventions. Curr Psychiatry Rep 15(8):381. \nhttps:\/\/doi.org\/10.1007\/s11920-013-0381-4","journal-title":"Curr Psychiatry Rep"},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"s5","DOI":"10.1192\/bjp.bp.112.119164","volume":"54","author":"PB Jones","year":"2013","unstructured":"Jones PB (2013) Adult mental health disorders and their age at onset. Br J Psychiatry Suppl 54:s5\u201310. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.112.119164","journal-title":"Br J Psychiatry Suppl"},{"key":"1244_CR18","doi-asserted-by":"publisher","first-page":"h824","DOI":"10.1136\/bmj.h824","volume":"350","author":"K Hopkins","year":"2015","unstructured":"Hopkins K, Crosland P, Elliott N, Bewley S, Clinical Guidelines Update Committee B (2015) Diagnosis and management of depression in children and young people: summary of updated NICE guidance. BMJ 350:h824. \nhttps:\/\/doi.org\/10.1136\/bmj.h824","journal-title":"BMJ"},{"issue":"50","key":"1244_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3238\/arztebl.2013.0854","volume":"110","author":"K Dolle","year":"2013","unstructured":"Dolle K, Schulte-Korne G (2013) The treatment of depressive disorders in children and adolescents. Dtsch Arztebl Int 110(50):854\u2013860. \nhttps:\/\/doi.org\/10.3238\/arztebl.2013.0854","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"1244_CR20","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1542\/peds.2006-1395","volume":"120","author":"AH Cheung","year":"2007","unstructured":"Cheung AH, Zuckerbrot RA, Jensen PS, Ghalib K, Laraque D, Stein RE, Group G-PS (2007) Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics 120(5):e1313\u2013e1326. \nhttps:\/\/doi.org\/10.1542\/peds.2006-1395","journal-title":"Pediatrics"},{"issue":"3","key":"1244_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","volume":"26","author":"CJ Bachmann","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, Schuiling-Veninga CC, Wijlaars L, Zito JM, Hoffmann F (2016) Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26(3):411\u2013419. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2016.02.001","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"1244_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30385-3","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(16)30385-3","journal-title":"Lancet"},{"issue":"11","key":"1244_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","volume":"3","author":"TA Furukawa","year":"2016","unstructured":"Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G (2016) Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry 3(11):1059\u20131066. \nhttps:\/\/doi.org\/10.1016\/S2215-0366(16)30307-8","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1244_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/cap.2009.0047","volume":"20","author":"D Cohen","year":"2010","unstructured":"Cohen D, Consoli A, Bodeau N, Purper-Ouakil D, Deniau E, Guile JM, Donnelly C (2010) Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders. J Child Adolesc Psychopharmacol 20(1):39\u201347. \nhttps:\/\/doi.org\/10.1089\/cap.2009.0047","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"1244_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3923","volume":"12","author":"P Enck","year":"2013","unstructured":"Enck P, Bingel U, Schedlowski M, Rief W (2013) The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12(3):191\u2013204. \nhttps:\/\/doi.org\/10.1038\/nrd3923","journal-title":"Nat Rev Drug Discov"},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jad.2017.03.024","volume":"215","author":"R Meister","year":"2017","unstructured":"Meister R, Jansen A, Harter M, Nestoriuc Y, Kriston L (2017) Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis. J Affect Disord 215:288\u2013298. \nhttps:\/\/doi.org\/10.1016\/j.jad.2017.03.024","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"1244_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.01.029","volume":"118","author":"W Rief","year":"2009","unstructured":"Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG (2009) Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 118(1\u20133):1\u20138. \nhttps:\/\/doi.org\/10.1016\/j.jad.2009.01.029","journal-title":"J Affect Disord"},{"issue":"14","key":"1244_CR28","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","volume":"287","author":"BT Walsh","year":"2002","unstructured":"Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA J Am Med Assoc 287(14):1840\u20131847","journal-title":"JAMA J Am Med Assoc"},{"issue":"11","key":"1244_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.euroneuro.2011.09.007","volume":"22","author":"M Parellada","year":"2012","unstructured":"Parellada M, Moreno C, Moreno M, Espliego A, de Portugal E, Arango C (2012) Placebo effect in child and adolescent psychiatric trials. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 22(11):787\u2013799. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2011.09.007","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"8","key":"1244_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.euroneuro.2009.04.007","volume":"19","author":"T Wohlfarth","year":"2009","unstructured":"Wohlfarth T, Kalverdijk L, Rademaker C, Schothorst P, Minderaa R, Gispen-de Wied C (2009) Psychopharmacology for children: from off label use to registration. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 19(8):603\u2013608. \nhttps:\/\/doi.org\/10.1016\/j.euroneuro.2009.04.007","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"10047","key":"1244_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","volume":"388","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 388(10047):881\u2013890. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(16)30385-3","journal-title":"Lancet"},{"issue":"10128","key":"1244_CR32","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391(10128):1357\u20131366. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(17)32802-7","journal-title":"Lancet"},{"issue":"1","key":"1244_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1176\/appi.ajp.2008.08020247","volume":"166","author":"JA Bridge","year":"2009","unstructured":"Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA (2009) Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 166(1):42\u201349. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2008.08020247","journal-title":"Am J Psychiatry"},{"issue":"15","key":"1244_CR34","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","volume":"297","author":"JA Bridge","year":"2007","unstructured":"Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA J Am Med Assoc 297(15):1683\u20131696. \nhttps:\/\/doi.org\/10.1001\/jama.297.15.1683","journal-title":"JAMA J Am Med Assoc"},{"issue":"10","key":"1244_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","volume":"74","author":"C Locher","year":"2017","unstructured":"Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J (2017) Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA psychiatry 74(10):1011\u20131020. \nhttps:\/\/doi.org\/10.1001\/jamapsychiatry.2017.2432","journal-title":"JAMA psychiatry"},{"issue":"1","key":"1244_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1192\/bjp.bp.106.031088","volume":"193","author":"EM Tsapakis","year":"2008","unstructured":"Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ (2008) Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry J Ment Sci 193(1):10\u201317. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.106.031088","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"1244_CR37","unstructured":"US Food and Drug Administration (2002) Review and evaluation of clinical data (NDA 20-152; supplement S-032; sponsor: Bristol-Myers Squibb; drug: nefazodone hydrochloride [Serzone]; material submitted: pediatric exclusivity supplement; date submitted: 4-16-02; PDUFA due date: 10-17-02; reviewer: Andrew D Mosholder, MD, MPH) (2-page version) \nhttp:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/UCM164073.pdf\n\n. Accessed 5 Jan 2017"},{"issue":"4","key":"1244_CR38","first-page":"299","volume":"12","author":"GJ Emslie","year":"2002","unstructured":"Emslie GJ, Findling RL, Rynn MA, Marcus RN, Fernandes LA, D\u2019Amico MF, Hardy SA (2002) Efficacy and safety of nefazadone in the treatment of adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 12(4):299","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1244_CR39","unstructured":"US Food and Drug Administration (2002) Pediatric supplement (NDA 20-415; supplement SE5-011; sponsor: organon; drug: mirtazapine [Remeron]; material submitted: pediatric supplement SE5-011; date submitted: 5\/1\/01; date received: 5\/7\/01; user fee due date: 3\/7\/02; medical reviewer: Ann-Kathryn Maust, MD) \nhttp:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/UCM164066.pdf\n\n. Accessed 5 Jan 2017"},{"issue":"7","key":"1244_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1469-7610.2005.01467.x","volume":"46","author":"AH Cheung","year":"2005","unstructured":"Cheung AH, Emslie GJ, Mayes TL (2005) Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 46(7):735\u2013754. \nhttps:\/\/doi.org\/10.1111\/j.1469-7610.2005.01467.x","journal-title":"J Child Psychol Psychiatry"},{"key":"1244_CR41","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions. Wiley, Chichester (UK)"},{"issue":"10","key":"1244_CR42","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006\u20131012. \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1244_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1753-2000-3-11","volume":"3","author":"RL Findling","year":"2009","unstructured":"Findling RL, Pagano ME, McNamara NK, Stansbrey RJ, Faber JE, Lingler J, Demeter CA, Bedoya D, Reed MD (2009) The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. Child Adolesc Psychiatry Ment Health 3(1):11. \nhttps:\/\/doi.org\/10.1186\/1753-2000-3-11","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"4","key":"1244_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/cap.2013.0146","volume":"24","author":"SD Atkinson","year":"2014","unstructured":"Atkinson SD, Prakash A, Zhang Q, Pangallo BA, Bangs ME, Emslie GJ, March JS (2014) A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 24(4):180\u2013189. \nhttps:\/\/doi.org\/10.1089\/cap.2013.0146","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1244_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/cap.2006.16.59","volume":"16","author":"R Berard","year":"2006","unstructured":"Berard R, Fong R, Carpenter DJ, Thomason C, Wilkinson C (2006) An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 16:59\u201375","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1244_CR46","unstructured":"US Food and Drug Administration (2002) Review and Evaluation of Clinical Data (NDA 20\u2013152; supplement S-032; sponsor: Bristol-Myers Squibb; drug: nefazodone hydrochloride [Serzone]; material submitted: Pediatric Exclusivity Supplement; date submitted: 4\u201316-02; PDUFA due date: 10\u201317-02; reviewer: Andrew D Mosholder, MD, MPH) (15-page redacted version). \nhttps:\/\/www.fda.gov\/downloads\/drugs\/developmentapprovalprocess\/developmentresources\/ucm376993.pdf\n\n. Accessed May 21 2018"},{"key":"1244_CR47","unstructured":"Lilly E (2004) Fluoxetine: Fluoxetine versus Placebo in Adolescent Depressed Patients. Available via \nhttp:\/\/art45-paediatric-studies-docs.ema.europa.eu\/GROUP%20F\/Fluoxetine\/fluoxetine%20B1Y-MCHCCJ%20Clinical%20Study%20Summary.pdf.\n\n Accessed 25 May 2018"},{"key":"1244_CR48","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archpsyc.1997.01830230069010","volume":"54","author":"GJ Emslie","year":"1997","unstructured":"Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J (1997) A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031\u20131037","journal-title":"Arch Gen Psychiatry"},{"key":"1244_CR49","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/01.CHI.0000024834.94814.9A","volume":"41","author":"GJ Emslie","year":"2002","unstructured":"Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG (2002) Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205\u20131215. \nhttps:\/\/doi.org\/10.1097\/01.CHI.0000024834.94814.9A","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"1244_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/01.chi.0000214189.73240.63","volume":"45","author":"GJ Emslie","year":"2006","unstructured":"Emslie GJ, Wagner KD, Kutcher S, Krulewicz S, Fong R, Carpenter DJ, Lipschitz A, Machin A, Wilkinson C (2006) Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 45(6):709\u2013719. \nhttps:\/\/doi.org\/10.1097\/01.chi.0000214189.73240.63","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"1244_CR51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/chi.0b013e31802f5f03","volume":"46","author":"GJ Emslie","year":"2007","unstructured":"Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y (2007) Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 46 (4):479\u2013488. \nhttps:\/\/doi.org\/10.1097\/chi.0b013e31802f5f03","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"1244_CR52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/CHI.0b013e3181a2b304","volume":"48","author":"GJ Emslie","year":"2009","unstructured":"Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S (2009) Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 48(7):721\u2013729. \nhttps:\/\/doi.org\/10.1097\/CHI.0b013e3181a2b304","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"1244_CR53","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/cap.2013.0096","volume":"24","author":"GJ Emslie","year":"2014","unstructured":"Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS (2014) A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 24(4):170\u2013179. \nhttps:\/\/doi.org\/10.1089\/cap.2013.0096","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1244_CR54","unstructured":"GSK (2013) A randomised, double-blind, placebo controlled, parallel group, flexible dose study to evaluate the efficacy and safety of Paxil\u00ae tablets in children and adolescents with major depressive disorder. \nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT00812812.\n\n Accessed 25 May 2018"},{"key":"1244_CR55","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00004583-200107000-00010","volume":"40","author":"MB Keller","year":"2001","unstructured":"Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP (2001) Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 40:762\u2013772","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1244_CR56","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jama.292.7.807","volume":"292","author":"J March","year":"2004","unstructured":"March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807\u2013820","journal-title":"JAMA"},{"issue":"3","key":"1244_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01.jcp.0000219051.40632.d5","volume":"26","author":"AL Knorring von","year":"2006","unstructured":"von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hulten A (2006) A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 26 (3):311\u2013315. \nhttps:\/\/doi.org\/10.1097\/01.jcp.0000219051.40632.d5","journal-title":"J Clin Psychopharmacol"},{"key":"1244_CR58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","volume":"290","author":"KD Wagner","year":"2003","unstructured":"Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D (2003) Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 290:1033\u20131041","journal-title":"JAMA"},{"key":"1244_CR59","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1176\/appi.ajp.161.6.1079","volume":"161","author":"KD Wagner","year":"2004","unstructured":"Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE (2004) A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161:1079\u20131083","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1244_CR60","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.chi.0000192250.38400.9e","volume":"45","author":"KD Wagner","year":"2006","unstructured":"Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K (2006) A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45 (3):280\u2013288. \nhttps:\/\/doi.org\/10.1097\/01.chi.0000192250.38400.9e","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1244_CR61","unstructured":"Pfizer (2016) A Multicenter, Randomized, Double-blind, Placebo-controlled, Fluoxetine-referenced, Parallel-group Study to evaluate the efficacy, safety and tolerability of desvenlafaxine succinate sustained release (Dvs Sr) in the treatment of children and adolescent outpatients with major depressive disorder. \nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT01372150.\n\n Accessed 25 May 2018"},{"key":"1244_CR62","unstructured":"Pfizer (2017) A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to evaluate the efficacy, safety and tolerability of desvenlafaxine succinate sustained-release (Dvs Sr) in the treatment of children and adolescent outpatients with major depressive disorder. \nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT01371734.\n\n Accessed 24 May 2018"},{"issue":"1","key":"1244_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","volume":"20","author":"TA Furukawa","year":"2005","unstructured":"Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N (2005) Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol 20(1):49\u201352","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"1244_CR64","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jclinepi.2015.02.006","volume":"68","author":"R Meister","year":"2015","unstructured":"Meister R, von Wolff A, Kriston L (2015) Odds ratios of treatment response were well approximated from continuous rating scale scores for meta-analysis. J Clin Epidemiol 68(7):740\u2013751. \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2015.02.006","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"1244_CR65","doi-asserted-by":"publisher","first-page":"e007768","DOI":"10.1136\/bmjopen-2015-007768","volume":"5","author":"X Zhou","year":"2015","unstructured":"Zhou X, Qin B, Whittington C, Cohen D, Liu Y, Del Giovane C, Michael KD, Zhang Y, Xie P (2015) Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis. BMJ Open 5(9):e007768. \nhttps:\/\/doi.org\/10.1136\/bmjopen-2015-007768","journal-title":"BMJ Open"},{"issue":"7414","key":"1244_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. \nhttps:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"3","key":"1244_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1\u201348","journal-title":"J Stat Softw"},{"issue":"7549","key":"1244_CR68","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P (2006) The cost of dichotomising continuous variables. BMJ 332(7549):1080. \nhttps:\/\/doi.org\/10.1136\/bmj.332.7549.1080","journal-title":"BMJ"},{"issue":"12","key":"1244_CR69","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1097\/00004583-200312000-00022","volume":"42","author":"HC Kraemer","year":"2003","unstructured":"Kraemer HC, Morgan GA, Leech NL, Gliner JA, Vaske JJ, Harmon RJ (2003) Measures of clinical significance. J Am Acad Child Adolesc Psychiatry 42(12):1524\u20131529. \nhttps:\/\/doi.org\/10.1097\/00004583-200312000-00022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"1244_CR70","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2165\/11316580-000000000-00000","volume":"32","author":"W Rief","year":"2009","unstructured":"Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J (2009) Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf 32(11):1041\u20131056. \nhttps:\/\/doi.org\/10.2165\/11316580-000000000-00000","journal-title":"Drug Saf"},{"issue":"4","key":"1244_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0165-0327(94)90101-5","volume":"31","author":"M Domken","year":"1994","unstructured":"Domken M, Scott J, Kelly P (1994) What factors predict discrepancies between self and observer ratings of depression? J Affect Disord 31(4):253\u2013259","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"1244_CR72","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jad.2009.11.011","volume":"124","author":"JD Carter","year":"2010","unstructured":"Carter JD, Frampton CM, Mulder RT, Luty SE, Joyce PR (2010) The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression. J Affect Disord 124(1\u20132):202\u2013206. \nhttps:\/\/doi.org\/10.1016\/j.jad.2009.11.011","journal-title":"J Affect Disord"},{"issue":"1","key":"1244_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-0327(99)00156-1","volume":"60","author":"MW Enns","year":"2000","unstructured":"Enns MW, Larsen DK, Cox BJ (2000) Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affect Disord 60(1):33\u201341","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"1244_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jad.2012.03.044","volume":"142","author":"M Zimmerman","year":"2012","unstructured":"Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA (2012) Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission. J Affect Disord 142(1\u20133):77\u201381. \nhttps:\/\/doi.org\/10.1016\/j.jad.2012.03.044","journal-title":"J Affect Disord"},{"issue":"5","key":"1244_CR75","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1176\/appi.ajp.159.5.728","volume":"159","author":"HS Mayberg","year":"2002","unstructured":"Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159(5):728\u2013737. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.159.5.728","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1244_CR76","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jpain.2015.06.013","volume":"16","author":"N Wrobel","year":"2015","unstructured":"Wrobel N, Fadai T, Sprenger C, Hebebrand J, Wiech K, Bingel U (2015) Are children the better placebo analgesia responders? An experimental approach. J Pain 16(10):1005\u20131011. \nhttps:\/\/doi.org\/10.1016\/j.jpain.2015.06.013","journal-title":"J Pain"},{"issue":"1","key":"1244_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/pr.2013.66","volume":"74","author":"K Weimer","year":"2013","unstructured":"Weimer K, Gulewitsch MD, Schlarb AA, Schwille-Kiuntke J, Klosterhalfen S, Enck P (2013) Placebo effects in children: a review. Pediatr Res 74(1):96\u2013102. \nhttps:\/\/doi.org\/10.1038\/pr.2013.66","journal-title":"Pediatr Res"},{"key":"1244_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-9-1","volume":"9","author":"LT Krogsboll","year":"2009","unstructured":"Krogsboll LT, Hrobjartsson A, Gotzsche PC (2009) Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 9:1. \nhttps:\/\/doi.org\/10.1186\/1471-2288-9-1","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1244_CR79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ctim.2012.12.010","volume":"21","author":"P Enck","year":"2013","unstructured":"Enck P, Klosterhalfen S (2013) The placebo response in clinical trials-the current state of play. Complement Ther Med 21(2):98\u2013101. \nhttps:\/\/doi.org\/10.1016\/j.ctim.2012.12.010","journal-title":"Complement Ther Med"},{"issue":"7","key":"1244_CR80","doi-asserted-by":"publisher","first-page":"e41778","DOI":"10.1371\/journal.pone.0041778","volume":"7","author":"A Khan","year":"2012","unstructured":"Khan A, Faucett J, Lichtenberg P, Kirsch I, Brown WA (2012) A systematic review of comparative efficacy of treatments and controls for depression. PLoS One 7(7):e41778. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0041778","journal-title":"PLoS One"},{"issue":"12","key":"1244_CR81","doi-asserted-by":"publisher","first-page":"e15591","DOI":"10.1371\/journal.pone.0015591","volume":"5","author":"TJ Kaptchuk","year":"2010","unstructured":"Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ (2010) Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 5(12):e15591. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0015591","journal-title":"PLoS One"},{"issue":"5","key":"1244_CR82","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000337053","volume":"81","author":"JM Kelley","year":"2012","unstructured":"Kelley JM, Kaptchuk TJ, Cusin C, Lipkin S, Fava M (2012) Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom 81(5):312\u2013314. \nhttps:\/\/doi.org\/10.1159\/000337053","journal-title":"Psychother Psychosom"},{"issue":"6","key":"1244_CR83","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/00004714-200212000-00006","volume":"22","author":"TE Wilens","year":"2002","unstructured":"Wilens TE, Cohen L, Biederman J, Abrams A, Neft D, Faird N, Sinha V (2002) Fluoxetine pharmacokinetics in pediatric patients. J Clin Psychopharmacol 22(6):568\u2013575","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"1244_CR84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/01.NMD.0000061144.16176.38","volume":"191","author":"A Khan","year":"2003","unstructured":"Khan A, Detke M, Khan SR, Mallinckrodt C (2003) Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis 191(4):211\u2013218. \nhttps:\/\/doi.org\/10.1097\/01.NMD.0000061144.16176.38","journal-title":"J Nerv Ment Dis"},{"issue":"4 Suppl 1","key":"1244_CR85","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/01.jcp.0000162810.76947.bf","volume":"25","author":"BT Walsh","year":"2005","unstructured":"Walsh BT, Sysko R (2005) Placebo control groups in trials of major depressive disorder among older patients. J Clin Psychopharmacol 25(4 Suppl 1):S29\u2013S33","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1244_CR86","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"I Kirsch","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5(2):e45. \nhttps:\/\/doi.org\/10.1371\/journal.pmed.0050045","journal-title":"PLoS Med"},{"issue":"5","key":"1244_CR87","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1192\/bjp.bp.115.173906","volume":"209","author":"J Rabinowitz","year":"2016","unstructured":"Rabinowitz J, Werbeloff N, Mandel FS, Menard F, Marangell L, Kapur S (2016) Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials. Br J Psychiatry J Ment Sci 209(5):427\u2013428. \nhttps:\/\/doi.org\/10.1192\/bjp.bp.115.173906","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"4","key":"1244_CR88","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mp.2015.53","volume":"21","author":"F Hieronymus","year":"2016","unstructured":"Hieronymus F, Emilsson JF, Nilsson S, Eriksson E (2016) Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry 21(4):523\u2013530. \nhttps:\/\/doi.org\/10.1038\/mp.2015.53","journal-title":"Mol Psychiatry"},{"issue":"11","key":"1244_CR89","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/sim.1752","volume":"23","author":"JP Higgins","year":"2004","unstructured":"Higgins JP, Thompson SG (2004) Controlling the risk of spurious findings from meta-regression. Stat Med 23(11):1663\u20131682. \nhttps:\/\/doi.org\/10.1002\/sim.1752","journal-title":"Stat Med"},{"issue":"3","key":"1244_CR90","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/sim.1023","volume":"21","author":"JA Berlin","year":"2002","unstructured":"Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI, Anti-Lymphocyte Antibody Induction Therapy Study G (2002) Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 21(3):371\u2013387","journal-title":"Stat Med"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-018-1244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-018-1244-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-018-1244-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T22:04:11Z","timestamp":1583359451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-018-1244-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,8]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s00787-018-1244-7","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,8]]},"assertion":[{"value":"11 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}